THE MARTHA FELDMAN AWARD

MARTHA FELDMAN

Martha Feldman started the Organization of Regulatory and Clinical Associates in 1993. Martha was a passionate professional. She was a truly gifted woman that used her intelligence to inspire so many lives, and made many contributions to the Pacific Northwest biomedical products arena. Martha was a fearless ground breaker and the advocate of all things related to science. She shared her pragmatic and often tongue-in-cheek perspective on regulatory affairs and what was needed in clinical trials. She provided valuable input and advice to those in the start-up and IP commercialization community. Martha was always a mentor and believed in her peers and students.

THE MARTHA FELDMAN AWARD

The first Martha Feldman Award was presented in 2022.

The Martha Feldman Award honors a Washington individual who has contributed to the field of regulatory affairs and clinical trials, supported colleagues, and advanced the understanding of regulatory affairs and clinical trials among professionals and the public.

2024 Martha Feldman Award recipient

 Lynn Rose, PhD

Associate Professor (affiliate)

UW School of Pharmacy, Biomedical Regulatory Affairs Master's in Science (BRAMS) program

Dr. Lynn Rose is an Associate Professor (affiliate) in the UW School of Pharmacy, where she is faculty in the Biomedical Regulatory Affairs master’s in science (BRAMS) program. She is also affiliated with the UW Institute of Translational Health Sciences, where she advises academic investigators on regulatory strategies for product development.  She previously held academic positions at Seattle Children’s Research Institute and the Benaroya Research Institute. While working in the biotechnology industry, she had the opportunity to oversee nonclinical, clinical, and regulatory programs and departments. This experience included participation on multiple drug development teams, two of which resulted in marketed products for the treatment of cystic fibrosis and two for hemostasis. Dr. Rose has expertise in biopharmaceutical product development, including clinical study designs, and identification of regulatory strategies for new medical products. Her research experience is in the field of immunology, with an emphasis on autoimmunity, infectious disease, and immuno-oncology. Dr. Rose earned her doctorate in immunology from the University of Geneva, Switzerland. 

Lynn is a member of the UW ITHS Steering Committee and a founding member of the DDAC. She is also a regulatory consultant for the ITHS Technology Development Center, providing regulatory guidance to academic inventors seeking to bring their medical product ideas to market. 

 2023 Martha Feldman Award recipient

Elizabeth Cross Nichol,

Program and Grants Manager, Life Science Washington Institute

Elizabeth believes that innovation improves health. This requires funding, successful implementation, perpetual learning, and persistence. At Life Science Washington Institute, Elizabeth has the best job, and takes very seriously, managing the grants that WA Commerce has provided. As an investor and co-founder of Apis Health Angels, modeled after the successful Seattle Angel Conference, Elizabeth educates entrepreneurs and investors in how to prepare for, evaluate through due diligence, and execute on early-stage seed funding. Everyone benefits when under-resourced founders with great ideas, develop their fundamentals, for a smooth path to market. As a startup founder at Downstream Therapeutics, she strategizes on how to best address reperfusion injury through a drug-device combination therapy.

Elizabeth has been a guest lecturer in the UW BRAMS program, a member of RAPS, and a strong advocate of ORCA as the local community for regulatory and clinical associates including several terms on the Board and two years as President. As a physical therapist, a health administrator, and an evaluator of technology, she is always exploring whether new ideas fit within a clinically effective, safe, patient-centered and, cost-effective approach. Elizabeth can be found speaking on panels to share resources, acting as a competition judge, and making connections. You likely will also find her geeking out about the spiral length of a hummingbird’s tongue, whether mulch or bone meal is a better tomato fertilizer, or which ice crystals make faster skiing. 

2022 Martha Feldman Award recipient

David Hammond

 Associate Teaching Professor and Associate Director,

UW BRAMS Biomedical Regulatory Affairs

Chair, IRB at Bastyr University

David Hammond has worked in the FDA regulated field for more than 25 years. He started as a clinical research coordinator first in Boise, Idaho, and then in Seattle. After deciding it was time for a change, he moved to the medical device industry. While working as a clinical research associate for a Class 3 medical device trial, he found that he really enjoyed things that plug in to things that you swallow (DISCLAIMER: he does not recommend swallowing the things that are plugged in). He spent the next decade working for a series of medical device companies and through a series of job changes that he thought were well thought out, but were viewed by his parents as the sign of someone who gets bored easily. He found himself unemployed in 2008 after being laid off when his employer underwent downsizing. This led to David deciding that his next adventure would be consulting, so with absolutely no planning, he began consulting with local biotechnology companies until, as he said, he found a real job. Thirteen years and zero real jobs later, he still consults among other activities. He is currently the principal consultant (well, really the only consultant) at Hammond Clinical Trial Consulting, the VP of Clinical, Regulatory, and Quality at MagForce USA (a nanomedicine company focusing on prostate cancer), Associate Teaching Professor in the BRAMS program at the University of Washington where he gets to tell bad jokes to students and they have to laugh if they want to pass, and the Director of the Office of Research Integrity and Chair of the IRB at Bastyr University.

David holds a CCRP from SOCRA and a CIP from PRIM&R. He has a BS in Zoology from the University of Idaho and a MS in Biomedical Regulatory Affairs from the University of Washington.